Responsive image

Common name


cumene

IUPAC name


cumene

SMILES


C(c1ccccc1)(C)C

Common name


cumene

IUPAC name


cumene

SMILES


C(c1ccccc1)(C)C

INCHI


InChI=1S/C9H12/c1-8(2)9-6-4-3-5-7-9/h3-8H,1-2H3

FORMULA


C9H12

Responsive image

Common name


cumene

IUPAC name


cumene





Molecular weight


120.192

clogP


2.828

clogS


-2.414

Frequency


0.0045





HBond Acceptor


0

HBond Donor


0

Total Polar
Surface Area


0

Number of Rings


1

Rotatable Bond


1

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD00804 Felbamate Responsive image Anticonvulsants; Nervous System; Antiepileptics; Cytochrome P-450 CYP2C19 Inducers; CYP2E1 Inhibitors; CYP2E1 Inducers; CYP2E1 Inducers (strong); CYP3A4 Inhibitors; For use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use.
FDBD01416 Tyloxapol Responsive image Surface-Active Agents; Expectorants; Detergents; Cough and Cold Preparations; Respiratory System; Used as a surfactant to aid liquefaction and removal of mucopurulent (containing mucus and pus) bronchopulmonary secretions, administered by inhalation through a nebulizer or with a stream of oxygen. Also investigated for use/treatment in cystic fibrosis and pediatric indications.
FDBD01456 Fospropofol Responsive image Hypnotics and Sedatives; For monitored anaesthesia care sedation in patients undergoing diagnostic procedures like bronchoscopy and colonscopy or minor surgical procedures like arthroscopy and bunionectomy.
FDBD01500 Pralatrexate Responsive image Antineoplastic Agents; Immunosuppressive Agents; Antimetabolites; Antineoplastic and Immunomodulating Agents; Folic Acid Analogues; Treatment of relapsed or refractory peripheral T-cell lymphoma.
FDBD01645 Netupitant Responsive image Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); Netupitant is an antiemitic drug approved by the FDA in October 2014 for use in combination with palonosetron for the prevention of acute and delayed vomiting and nausea associated with cancer chemotherapy including highly emetogenic chemotherapy.
FDBD01903 isoprocarb Responsive image Insecticide Insecticide
FDBD02304 etofenprox Responsive image Insecticide Insecticide
FDBD02306 halfenprox Responsive image Insecticide Insecticide
FDBD02356 bromobutide Responsive image Herbicide Herbicide
FDBD02771 cumyluron Responsive image Herbicide Herbicide
13 , 2
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
2gpp_ligand_1_1.mol2 2gpp 1 -7.66 c1(ccccc1)C(C)C 9
2zas_ligand_1_1.mol2 2zas 1 -7.61 C(C)(C)c1ccccc1 9
2p7g_ligand_1_0.mol2 2p7g 1 -7.54 c1ccc(cc1)C(C)C 9
4w54_ligand.mol2 4w54 1 -7.52 C(C)c1ccccc1 9
1mh5_ligand_2_0.mol2 1mh5 1 -7.43 CCc1ccccc1 8
186l_ligand_2_0.mol2 186l 1 -7.41 C(c1ccccc1)C 8
4w57_ligand_2_0.mol2 4w57 1 -7.41 CCc1ccccc1 8
1045 , 105